首页> 外文期刊>The Journal of Urology >Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
【24h】

Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.

机译:根治性耻骨后前列腺切除术+睾丸切除术与单纯睾丸切除术治疗pTxN +前列腺癌:匹配的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Untreated stage pTxN+ prostate cancer is associated with a poor outcome. Monotherapy (surgery, radiation, hormonal therapy) alone is associated with a high progression rate. We evaluate whether radical prostatectomy and pelvic lymphadenectomy plus early adjuvant orchiectomy impart a survival advantage compared to pelvic lymphadenectomy and orchiectomy alone in a matched cohort of patients. MATERIALS AND METHODS: Between 1966 and 1995, 382 and 79 patients with stage pTxN+ prostate cancer underwent pelvic lymphadenectomy and radical prostatectomy plus early adjuvant orchiectomy (within 3 months of prostatectomy), and pelvic lymphadenectomy and orchiectomy only, respectively. We selected 79 matched controls from the prostatectomy plus orchiectomy group for the orchiectomy group. Patients were matched according to the number of positive nodes, clinical grade, clinical stage, age, year of surgery and preoperative prostate specific antigen (after 1987). The Kaplan-Meier method and stratified Cox proportional hazards model were used to estimate overall and cause specific survival for the 2 groups. RESULTS: There was an overall survival advantage at 10 years for the prostatectomy plus orchiectomy (66+/-6%) compared to the orchiectomy (28+/-6%) group (p <0.001, risk ratio 0.36, 95% confidence interval 0.20 to 0.66). There was also an advantage in cause specific survival at 10 years in the prostatectomy plus orchiectomy (79+/-5%) versus the orchiectomy (39+/-7%) group (p <0.001, relative risk 0.28, 95% confidence interval 0.13 to 0.59). After 1987, when matched on preoperative prostate specific antigen, the apparent survival advantage at 5 years with radical prostatectomy was smaller (79+/-8 versus 63+/-9% orchiectomy) and not significant (p = 0.19). CONCLUSIONS: This retrospective study of patients with stage pTxN+ PC suggests that radical prostatectomy with early adjuvant orchiectomy may provide a significant advantage in overall and cause specific survival compared to orchiectomy alone.
机译:目的:未经治疗的pTxN +期前列腺癌与不良预后相关。单独进行单一疗法(手术,放射线,激素疗法)与高进展率相关。我们评估了在匹配的一组患者中,与单纯盆腔淋巴结清扫术和睾丸切除术相比,根治性前列腺切除术和盆腔淋巴结清扫术加上早期辅助睾丸切除术是否具有生存优势。材料与方法:在1966年至1995年之间,分别对382例和79例pTxN +前列腺癌患者进行了盆腔淋巴结清扫术和根治性前列腺切除术加早期辅助性睾丸切除术(在前列腺切除术的3个月内),以及仅进行了盆腔淋巴结清扫术和睾丸切除术。我们从前列腺切除术和睾丸切除术组中选择了79个匹配的对照作为睾丸切除术组。根据阳性淋巴结数目,临床等级,临床分期,年龄,手术年份和术前前列腺特异性抗原(1987年以后)对患者进行匹配。使用Kaplan-Meier方法和分层Cox比例风险模型评估两组的总体生存率和特定生存率。结果:与睾丸切除术(28 +/- 6%)组相比,前列腺切除术和睾丸切除术在10年时具有总体生存优势(p +/- 0.001,风险比0.36,置信区间为95%) 0.20至0.66)。与睾丸切除术(39 +/- 7%)组相比,前列腺切除术+睾丸切除术(79 +/- 5%)在10年时的特定生存率方面也有优势(p <0.001,相对风险0.28,95%置信区间0.13至0.59)。 1987年以后,当与术前前列腺特异性抗原相匹配时,根治性前列腺切除术在5年时的明显生存优势较小(79 +/- 8对63 +/- 9%睾丸切除术),但无统计学意义(p = 0.19)。结论:这项对pTxN + PC期患者的回顾性研究表明,与单纯的睾丸切除术相比,根治性前列腺切除术与早期辅助性睾丸切除术可能在总体上具有显着优势,并能导致特定的生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号